Skip to content

Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy

Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00720980
Enrollment
6
Registered
2008-07-23
Start date
2008-05-31
Completion date
2008-07-31
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Granuloma Annulare

Keywords

granuloma annulare, ROM

Brief summary

Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or disseminated form can occur. The etiology of granuloma annulare is unknown, however, multiple inciting factors have been proposed. The purpose of the investigators is to review the outcomes of treatment of granuloma annulare (GA) resistant to standard regimens that resolved after a 3-months treatment course of monthly rifampin, ofloxacin, and minocycline (ROM) therapy, successfully used to treat paucibacillary leprosy, a disease with clinical and histopathologic similarity to GA.

Detailed description

We will document the regimen treatment each patient has had and then review the following from the patient's chart to target our specific aims as outlined above. 1. What previous treatment options have been or/are currently being used? 2. How long did the patient take the treatment for? 3. Was the patient able to discontinue or become less dependent on prior treatment? 4. Was the disease process slowed by the treatment?; 5. Were there any side effects that the patient experienced with treatment?

Interventions

None listed

Sponsors

Henry Ford Health System
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with granuloma annulare who are resistent to the standard treatment.

Exclusion criteria

* Response to the standard treatment of granuloma annulare.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026